Thomas Willoughby joined BioPharma Services in 2022 as the Vice President of Business Development. Thomas has been in the CRO industry for over 20 years, having held positions of increasing responsibility within Project Management and Business Development, with a focus on Phase 1 services. Based on his experience and thorough understanding of the drug development process, Thomas looks forward to collaborating with you to achieve your Phase 1 drug development needs.
Recent Posts
- Exploring the importance and ways to achieve Steady State in Pharmacokinetics
- Good Laboratory Practice Accreditation by the Standards Council of Canada
- Data Cleaning and Query Management Importance in EDC
- Computerized Assessments of Cognitive and Subjective Drug Effects Used in Clinical Trials
- Drug Development Pathway for New & Generic Narrow Therapeutic Index Drugs
Recent Comments